Elanco Animal Health Incorporated today announced several milestones to defend against deadly canine parvovirus, or “parvo” — a disease that affects more than 330,000 puppies annually, with a mortality rate up to 91% without supportive care.
Read MoreThe state budget Indiana’s Senate will consider beginning this week includes funding a proposed expansion for White River State Park, which will develop park space from the former General Motors stamping plant property.
Read MoreElanco Animal Health Incorporated announced the U.S. Food and Drug Administration has approved Zenreli, a highly effective and convenient once-daily oral JAK inhibitor for control of itching associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.
Read MoreElanco Animal Health Incorporated today announced the U.S. Food and Drug Administration has completed its comprehensive, multi-year review of Bovaer, a first-in-class methane-reducing feed ingredient, and determined the product meets safety and efficacy requirements for use in lactating dairy cattle.
Read More
